Palliative care at home: a small, early trial that ended early

NCT ID NCT03128060

First seen Nov 01, 2025

Summary

This study tested whether bringing a team of doctors, nurses, social workers, and chaplains into the home could improve symptoms and quality of life for people with cancer, heart failure, or COPD. The goal was to enroll over 1,100 patients, but the trial was terminated early and only 35 people took part. Because of the small size and early stop, the results are limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONGESTIVE HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • USC Davis School of Gerontology

    Los Angeles, California, 90089, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

home-based palliative care (team of doctor, nurse, social worker, chaplain)

What this could lead to

If successful, this approach could show that bringing palliative care into the home improves symptom control and emotional well-being for patients with serious illnesses.

What could go wrong

The trial was terminated early and enrolled only 35 people, far fewer than planned. This makes it hard to draw firm conclusions. Results may not apply broadly.

Conditions

The condition(s) this trial relates to.

cancer chronic obstructive pulmonary disease congestive heart failure heart failure neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.